Innovent Biologics, Inc.

Equities

1801

KYG4818G1010

Market Closed - Hong Kong S.E. Other stock markets 01:38:03 08/05/2026 pm IST			5-day change	1st Jan Change
90.00 ^HKD	-1.21%		0.00%	+18.03%

30/04	Innovent Biologics, Inc. Reports Product Revenue Results for the First Quarter of 2026	CI
30/04	Innovent Biologics' Product Revenue Jumps 50% in Q1 2026	MT

Transcript : Innovent Biologics, Inc., Takeda Pharmaceutical Company Limited - Special Call

Published on 10/22/2025 at 08:53 pm IST - Modified on 10/22/2025 at 10:50 pm IST

S&P Capital IQ

Presenter Speech
Zhengwei Song (Executives)

Okay. So good evening, and good morning, dear investors and analysts. So thank you all for joining Innovent Investor call today. Earlier today, we just

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Innovent Biologics, Inc.

30/04	Innovent Biologics, Inc. Reports Product Revenue Results for the First Quarter of 2026	CI
30/04	Innovent Biologics' Product Revenue Jumps 50% in Q1 2026	MT
30/04	Innovent Biologics posts Q1 2026 total product revenue over RMB3.8 billion	RE
28/04	Sino Biopharmaceutical Limited Announces Executive Appointments	CI
23/04	Rising Crude Prices Lower Asian Stock Markets	MT
22/04	Pfizer GLP-1 weight loss drug available for pre-order in China	RE
22/04	Nuvation Bio Inc. Announces Highly Durable Responses For IBTROZI (Taletrectinib) In Advanced ROS1-Positive Non-Small Cell Lung Cancer	CI
10/04	Innovent Biologics Announces Pre-Clinical Results of IBI3055, A Tri-Specific T Cell Engager Targeting Autoimmune Diseases	CI
10/04	Medicenna Therapeutics Corp. Appoints Nageatte Ibrahim as Chief Medical Officer	CI
09/04	Medicenna Therapeutics Names New Chief Medical Officer; Rose 6.5% From Near 52 Week Lows Wednesday	MT
08/04	Alphamab Oncology Announces Changes in Joint Company Secretary of the Company, Effective April 8, 2026	CI
30/03	Eli Lilly Strikes AI Drug Discovery Deal With InSilico Worth Up to $2.75 Billion -- Update	DJ
27/03	Innovent Biologics Shares Surge After Swing to Profitability	DJ
26/03	Innovent Biologics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
26/03	Innovent Biologics Turns to Profit in 2025	MT